Investigation Overview
San Diego, Sept. 8, 2011 (Shareholders Foundation) -- The announcement by PerkinElmer, Inc that is wants to acquire all of the outstanding common stock of Caliper Life Sciences Inc. for $10.50 per NASDAQ:CALP share prompted an investigation on behalf of investors of Caliper Life Sciences Inc. (NASDAQ: CALP) concerning whether the offer to acquire Caliper Life Sciences and the buyout p...
You must register (for free) or login to view the entire investigation.